-
1
المؤلفون: Frederico Sala, Cesare Cosentino, Olha Holubovska, Miguel Muzzio, Jindrich Cinatl, Victor Margitich, David Boltz, Aartjan J. W. te Velthuis, Lutz Mueller, Yuriy Lebed, Denisa Bojkova, Stefano Elli, Xinjian Peng, Holger Stammer, Alla Mironenko, Marco Guerrini, Jens Milde, Andrew Goy, Marco Bechtel
المصدر: Biomedicines
medRxiv
article-version (status) pre
article-version (number) 1مصطلحات موضوعية: SARS-CoV-2, business.industry, viruses, Metabolite, virus diseases, COVID-19, FAV00A, Pharmacology, Interim analysis, medicine.disease_cause, Placebo, Group A, Article, Herd immunity, Clinical trial, chemistry.chemical_compound, molecular dynamics simulation, chemistry, RNA polymerase, Amizon, medicine, business, Coronavirus
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ed77d3f92e3dc8c3d484bdad7a97e0e
https://doi.org/10.1101/2021.01.05.21249237